|
GB0218831D0
|
|
Biodegradable polymer
|
|
GB0218828D0
|
|
Anaesthetic conjugate for international delivery
|
|
GB0218830D0
|
|
Anaesthetic conjugate
|
|
GB0218827D0
|
|
Anaesthetic compounds and conjugates thereof
|
|
GB0218829D0
|
|
Anaesthetic compounds and conjugates thereof
|
|
US6919067B2
|
|
Compositions comprising a tissue glue and therapeutic agents
|
|
GB0115076D0
|
|
Composition
|
|
GB0108065D0
|
|
Viral vectors
|
|
GB0027164D0
|
|
Molecules for intracellular delivery,therapy and target validation
|
|
GB0014971D0
|
|
Composition
|
|
WO0075351A1
|
|
Siv-based packaging-defficient vectors
|
|
GB0012497D0
|
|
Antiviral therapy
|
|
GB9916911D0
|
|
Defective packaging non-oncoviral vectors
|
|
GB9913459D0
|
|
Defective packaging non-oncoviral vectors
|
|
US5948384A
|
|
Particulate agents
|
|
EP0752000A1
|
|
Packaging-deficient lentiviruses
|
|
GB9425026D0
|
|
Packaging-defective vectors
|
|
GB9405875D0
|
|
Recombinant molecules and their use in gene transfer
|
|
GB9405876D0
|
|
Modified virus and its use as a vector
|
|
CA2557882A1
|
|
Defective packaging non-oncoviral vectors based on mpmv and hiv
|
